Cue Biopharma Statistics Share Statistics Cue Biopharma has 76.85M
shares outstanding. The number of shares has increased by 54.9%
in one year.
Shares Outstanding 76.85M Shares Change (YoY) 54.9% Shares Change (QoQ) 18.94% Owned by Institutions (%) 15.36% Shares Floating 76.58M Failed to Deliver (FTD) Shares 167 FTD / Avg. Volume 0.06%
Short Selling Information The latest short interest is 665.93K, so 0.87% of the outstanding
shares have been sold short.
Short Interest 665.93K Short % of Shares Out 0.87% Short % of Float 0.87% Short Ratio (days to cover) 5.16
Valuation Ratios The PE ratio is -1.51 and the forward
PE ratio is -1.57.
Cue Biopharma's PEG ratio is
0.04.
PE Ratio -1.51 Forward PE -1.57 PS Ratio 6.61 Forward PS 8.2 PB Ratio 3.51 P/FCF Ratio -1.69 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cue Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.84,
with a Debt / Equity ratio of 0.51.
Current Ratio 1.84 Quick Ratio 1.84 Debt / Equity 0.51 Debt / EBITDA -0.24 Debt / FCF -0.24 Interest Coverage -52.14
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $226.51K Profits Per Employee $-992.05K Employee Count 41 Asset Turnover 0.29 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 4.5% in the
last 52 weeks. The beta is 1.59, so Cue Biopharma's
price volatility has been higher than the market average.
Beta 1.59 52-Week Price Change 4.5% 50-Day Moving Average 0.79 200-Day Moving Average 0.92 Relative Strength Index (RSI) 41 Average Volume (20 Days) 265,117
Income Statement In the last 12 months, Cue Biopharma had revenue of 9.29M
and earned -40.67M
in profits. Earnings per share was -0.72.
Revenue 9.29M Gross Profit 9.29M Operating Income -41.5M Net Income -40.67M EBITDA -37.53M EBIT -39.88M Earnings Per Share (EPS) -0.72
Full Income Statement Balance Sheet The company has 22.46M in cash and 8.88M in
debt, giving a net cash position of 13.58M.
Cash & Cash Equivalents 22.46M Total Debt 8.88M Net Cash 13.58M Retained Earnings -341.86M Total Assets 40.71M Working Capital 11.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -36.33M
and capital expenditures -66K, giving a free cash flow of -36.4M.
Operating Cash Flow -36.33M Capital Expenditures -66K Free Cash Flow -36.4M FCF Per Share -0.65
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -446.86% and -437.97%.
Gross Margin 100% Operating Margin -446.86% Pretax Margin -437.97% Profit Margin -437.97% EBITDA Margin -404.09% EBIT Margin -446.86% FCF Margin -391.89%
